J Korean Med Sci.  2022 Jun;37(22):e176. 10.3346/jkms.2022.37.e176.

Comparison of Initial Presentation of Pediatric Diabetes Before and During the Coronavirus Disease 2019 Pandemic Era

• Lee Y
• Kim M
• Oh K
• Kang E
• Rhie YJ
• Lee J
• Hong YH
• Shin YL
• Kim JH

• KMID: 2530418
• DOI: http://doi.org/10.3346/jkms.2022.37.e176

Abstract

Background
Hospital visitation has become challenging during the coronavirus disease 2019 pandemic because of quarantine measures and fear of infection. Consequently, newly diagnosed patients may present with more severe diseases during the pandemic. The present study analyzed the differences in the initial clinical presentations of newly diagnosed patients with type 1 diabetes (T1D) and type 2 diabetes (T2D), comparing pre-pandemic and pandemic periods.
Methods
Newly diagnosed patients with T1D or T2D and aged < 18 years during 2018–2020 were included in the study. Data were collected retrospectively from four academic centers in Gyeonggi-do, South Korea. Initial clinical data were compared between the pre-pandemic (2018–2019) and pandemic (2020) periods.
Results
In the pre-pandemic and pandemic periods, 99 patients (41 T1D and 58 T2D patients) and 84 patients (51 T1D and 33 T2D patients) were identified, respectively. During the pandemic, the proportion of diabetic ketoacidosis (DKA) cases increased compared to the pre-pandemic period (21.2% during 2018–2019 vs. 38.1% in 2020; P = 0.012). In the prepandemic and pandemic periods, initial pH was 7.32 ± 0.14 and 7.27 ± 0.15, respectively (P = 0.040), and HbA1c values were 11.18 ± 2.46% and 12.42 ± 2.87%, respectively (P = 0.002). During the pandemic, there was an increased risk of DKA in patients with T1D (odds ratio, 2.42; 95% confidence interval, 1.04–5.62; P = 0.040).
Conclusion
During the pandemic, the proportion of DKA in newly diagnosed patients with T1D increased and clinical parameters showed a deteriorating pattern. Increased awareness of pediatric diabetes, especially DKA, could facilitate visit to the hospital for an early diagnosis; thus, reducing the number of DKA cases during the pandemic era.

Keyword

Diabetic Ketoacidosis; COVID-19; Diabetes Mellitus; Child; Adolescents

Reference

1. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020; 12(4):E372. PMID: 32230900.

2. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020; 35(5):e61. PMID: 32030925.

3. Boserup B, McKenney M, Elkbuli A. The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States. Am J Emerg Med. 2020; 38(9):1732–1736. PMID: 32738468.

4. Mantica G, Riccardi N, Terrone C, Gratarola A. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Public Health. 2020; 183:40–41. PMID: 32417567.

5. Cherubini V, Gohil A, Addala A, Zanfardino A, Iafusco D, Hannon T, et al. Unintended consequences of coronavirus disease-2019: remember general pediatrics. J Pediatr. 2020; 223:197–198. PMID: 32437758.

6. Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020; 324(8):801–804. PMID: 32702751.

7. Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A. Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020; 43(11):2870–2872. PMID: 32778554.

8. Alaqeel A, Aljuraibah F, Alsuhaibani M, Huneif M, Alsaheel A, Dubayee MA, et al. The impact of COVID-19 pandemic lockdown on the incidence of new-onset type 1 diabetes and ketoacidosis among Saudi children. Front Endocrinol (Lausanne). 2021; 12:669302. PMID: 33868185.

9. Sellers EAC, Pacaud D. Diabetic ketoacidosis at presentation of type 1 diabetes in children in Canada during the COVID-19 pandemic. Paediatr Child Health. 2021; 26(4):208–209. PMID: 34127934.

10. Loh C, Weihe P, Kuplin N, Placzek K, Weihrauch-Blüher S. Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic. Metabolism. 2021; 122:154842. PMID: 34332999.

11. Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes. 2021; 22(4):552–557. PMID: 33745226.

12. Chao LC, Vidmar AP, Georgia S. Spike in diabetic ketoacidosis rates in pediatric type 2 diabetes during the COVID-19 pandemic. Diabetes Care. 2021; 44(6):1451–1453. PMID: 33905347.

13. Misra S, Barron E, Vamos E, Thomas S, Dhatariya K, Kar P, et al. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol. 2021; 9(10):671–680. PMID: 34481558.

14. Atlas G, Rodrigues F, Moshage Y, Welch J, White M, O’Connell MA. Presentation of paediatric type 1 diabetes in Melbourne, Australia during the initial stages of the COVID-19 pandemic. J Paediatr Child Health. 2020; 56(10):1654–1655. PMID: 32959935.

15. Kempegowda P, Melson E, Johnson A, Wallett L, Thomas L, Zhou D, et al. Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes. Endocr Connect. 2021; 10(4):371–377. PMID: 33666571.

16. Lee MS, Lee R, Ko CW, Moon JE. Increase in blood glucose level and incidence of diabetic ketoacidosis in children with type 1 diabetes mellitus in the Daegu-Gyeongbuk area during the coronavirus disease 2019 (COVID-19) pandemic: a retrospective cross-sectional study. J Yeungnam Med Sci. 2022; 39(1):46–52. PMID: 34433241.

17. Han MJ, Heo JH. Increased Incidence of pediatric diabetic ketoacidosis after COVID-19: a two-center retrospective study in Korea. Diabetes Metab Syndr Obes. 2021; 14:783–790. PMID: 33654417.

18. American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2019 . Diabetes Care. 2019; 42(Suppl 1):S13–S28. PMID: 30559228.

19. Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19(Suppl 27):155–177. PMID: 29900641.

20. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018; 61(5):135–149. PMID: 29853938.

21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604–612. PMID: 19414839.

22. Boboc AA, Novac CN, Ilie MT, Ieșanu MI, Galoș F, Bălgrădean M, et al. The impact of SARS-CoV-2 pandemic on the new cases of T1DM in children. A single-centre cohort study. J Pers Med. 2021; 11(6):551. PMID: 34199272.

23. Gottesman BL, Yu J, Tanaka C, Longhurst CA, Kim JJ. Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic. JAMA Pediatr. 2022; 176(4):414–415. PMID: 35072727.

24. Chae HW, Seo GH, Song K, Choi HS, Suh J, Kwon A, et al. Incidence and prevalence of type 1 diabetes mellitus among Korean children and adolescents between 2007 and 2017: an epidemiologic study based on a national database. Diabetes Metab J. 2020; 44(6):866–874. PMID: 33142054.

25. Kim JH, Lee CG, Lee YA, Yang SW, Shin CH. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatr Diabetes. 2016; 17(7):519–524. PMID: 26420382.

26. Lee HJ, Yu HW, Jung HW, Lee YA, Kim JH, Chung HR, et al. Factors associated with the presence and severity of diabetic ketoacidosis at diagnosis of type 1 diabetes in Korean children and adolescents. J Korean Med Sci. 2017; 32(2):303–309. PMID: 28049242.

27. Park JM, Yoo EG, Kim DH. Type 2 diabetes mellitus in children. J Korean Pediatr Soc. 2002; 45(5):646–653.

28. Yun KA, Lee YA, Shin CH, Yang SW. Clinical course of childhood and adolescence onset type 2 diabetes mellitus. J Korean Soc Pediatr Endocrinol. 2009; 14(1):19–24.

29. Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. 2020; 4(4):1059–1071. PMID: 33253013.

30. Vose JM. Delay in cancer screening and diagnosis during the COVID-19 pandemic: what is the cost? Oncology (Williston Park). 2020; 34(9):343. PMID: 32965661.

31. Elbarbary NS, Dos Santos TJ, de Beaufort C, Agwu JC, Calliari LE, Scaramuzza AE. COVID-19 outbreak and pediatric diabetes: perceptions of health care professionals worldwide. Pediatr Diabetes. 2020; 21(7):1083–1092. PMID: 32686287.

32. Choi DH, Jung JY, Suh D, Choi JY, Lee SU, Choi YJ, et al. Impact of the COVID-19 outbreak on trends in emergency department utilization in children: a multicenter retrospective observational study in Seoul metropolitan area, Korea. J Korean Med Sci. 2021; 36(5):e44. PMID: 33527786.